Additionally, the discovery of API as a HuR activator and its ability to promote osteogenesis through the formation of HuR‐positive SGs and β‐catenin nuclear translocation offers a promising new approach to treating osteoporosis. Here, ELAVL1 is linked to osteoporosis.